NovoCure (NVCR) Depreciation and Depletion (2014 - 2015)
NovoCure recorded quarterly Depreciation and Depletion of -$657000.0 in Q4 2015, down 13.67% quarter-over-quarter from -$578000.0 in Q4 2014, and down 13.67% year-over-year from -$761014.0 in Q4 2014.
NovoCure's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at -$657000.0 for Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 308.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -657,000.00 |
| Dec 31, 2015 | -657,000.00 |
| Dec 31, 2014 | -578,000.00 |
| Dec 31, 2014 | -578,000.00 |